Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age 18-64 Years”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Study completedNCT01416571
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Monovalent Pandemic H5N1 Vaccine in Adults

Who this might be right for
Influenza
GlaxoSmithKline 78
Testing effectiveness (Phase 2)Study completedNCT00771615
What this trial is testing

Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years

Who this might be right for
Influenza
GlaxoSmithKline 469
Post-approval studies (Phase 4)Looking for participantsNCT07730450
What this trial is testing

Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Who this might be right for
COVID-19 Vaccines
BioNTech SE 200
Post-approval studies (Phase 4)Study completedNCT05514002
What this trial is testing

Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years

Who this might be right for
Influenza, Human
Centers for Disease Control and Prevention 3,988
Testing effectiveness (Phase 2)Study completedNCT05175742
What this trial is testing

PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

Who this might be right for
Covid19 Vaccine
Providence Therapeutics Holdings Inc. 565
Post-approval studies (Phase 4)Study completedNCT03722589
What this trial is testing

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Who this might be right for
Influenza
Centers for Disease Control and Prevention 944
Large-scale testing (Phase 3)Study completedNCT03301051
What this trial is testing

Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Diseases+2 more
Medicago 10,160
Early research (Phase 1)Study completedNCT01659086
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 422
Testing effectiveness (Phase 2)Study completedNCT00540228
What this trial is testing

Study to Evaluate an Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 1,006
Testing effectiveness (Phase 2)WithdrawnNCT01008956
What this trial is testing

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Who this might be right for
Influenza
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Large-scale testing (Phase 3)Study completedNCT01389479
What this trial is testing

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Who this might be right for
Influenza
GlaxoSmithKline 1,000
Testing effectiveness (Phase 2)Study completedNCT00889889
What this trial is testing

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination

Who this might be right for
Influenza
Abbott Biologicals 1,270
Testing effectiveness (Phase 2)Ended earlyNCT00565799
What this trial is testing

A Pilot Study of Metabolic Effects of Omentectomy

Who this might be right for
Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet TherapyAge 18-64 Years
NYU Langone Health 11
Large-scale testing (Phase 3)Study completedNCT01712984
What this trial is testing

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 3,360
Post-approval studies (Phase 4)Study completedNCT06518577
What this trial is testing

Immunogenicity of Influenza Vaccinations

Who this might be right for
Influenza
Duke University 606
Large-scale testing (Phase 3)Study completedNCT00464672
What this trial is testing

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Who this might be right for
Influenza
Novartis 1,893
Post-approval studies (Phase 4)Study completedNCT03598439
What this trial is testing

Randomized Influenza Vaccine Evaluation of Immune Response

Who this might be right for
Influenza
Marshfield Clinic Research Foundation 366
Post-approval studies (Phase 4)Study completedNCT00531596
What this trial is testing

Evaluation of Adhesion and Dermal Tolerability of EMSAM

Who this might be right for
Healthy
Somerset Pharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT00522067
What this trial is testing

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

Who this might be right for
Influenza Disease
Novartis Vaccines 52
Next Page